All Stories

  1. HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: SAR and Lead Optimization Using CoMFA and CoMSIA Studies (1995-2016)
  2. Integrative approaches in HIV-1 non-nucleoside reverse transcriptase inhibitor design